Single-Cell RNA-Seq Revealed the Immune Microenvironment Reprogramming by Dexmedetomidine Treatment in Ischemic Stroke
Molecular Neurobiology · 2025
DOI: 10.1007/s12035-025-05237-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Neurobiology, 2025. Verfasst von Wenyi Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200336, China. Hauptthemen laut MEDLINE: Dexmedetomidine, Ischemic Stroke, Single-Cell Analysis, RNA-Seq. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Anesthesiology and Critical Care Medicine Master and Doctor Innovation Talent Base Fundation of Changning District, Shanghai Natural Science Foundation.
Themen: Schlaganfall
Abstract (Originalsprache)
Prior studies have indicated that the neuroprotective effects of dexmedetomidine (DEX) in cerebral ischemia, yet its mechanisms remain elusive. Using multi-omics approaches (RNA-seq, metabolomics, and single-cell RNA-seq), we discovered that DEX pretreatment significantly reduced cerebral infarct volume and improved neurological function in middle cerebral artery occlusion (MCAO) mice compared to PBS controls. Single-cell analysis revealed that DEX preserved microglial phagocytic function via metabolic regulation, leading to reduced microglial apoptosis and attenuated immune dysregulation-including decreased chemotactic neutrophils, B cells, and antigen-presenting fibroblasts. These cellular changes were corroborated by transcriptomic and metabolic profiles showing suppressed apoptosis and inflammation. Mechanistically, we identified HK2 (hexokinase 2) as a key regulator of microglial homeostasis, with its expression correlating with microglial migration, proliferation, and inflammation, findings validated in oxygen-glucose deprivation models. Collectively, our results demonstrate that DEX protects against cerebral ischemia-reperfusion injury by maintaining immune microenvironment homeostasis through microglial metabolic reprogramming mediated by HK2. This multi-omics study provides mechanistic insights supporting DEX's translational potential in ischemic stroke therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200336, China.
- Department of Anesthesiology, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200030, China.
- Hongqiao International Institute of Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200336, China.
- Department of Anesthesiology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200336, China. Wsy2785@shtrhospital.com.
- Department of Anesthesiology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200336, China. zhangjunfeng@sjtu.edu.cn.
- Department of Anesthesiology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200336, China. gmzhangyj@126.com.
Förderung
- National Natural Science Foundation of China
- Anesthesiology and Critical Care Medicine Master and Doctor Innovation Talent Base Fundation of Changning District
- Shanghai Natural Science Foundation
Zitieren
APA
Zhang, W., Wang, X., Zhang, B., Yi, M., Lu, Y., Wang, S., Zhang, J., & Zhang, G. (2025). Single-Cell RNA-Seq Revealed the Immune Microenvironment Reprogramming by Dexmedetomidine Treatment in Ischemic Stroke. Molecular Neurobiology. https://doi.org/10.1007/s12035-025-05237-1
Vancouver
Zhang W, Wang X, Zhang B, Yi M, Lu Y, Wang S, et al. Single-Cell RNA-Seq Revealed the Immune Microenvironment Reprogramming by Dexmedetomidine Treatment in Ischemic Stroke. Molecular Neurobiology. 2025. doi:10.1007/s12035-025-05237-1
BibTeX
@article{Zhang2025,
author = {Zhang, Wenyi and Wang, Xingyun and Zhang, Bing and Yi, Minjiang and Lu, Yinzhong and Wang, Shuyan and Zhang, Junfeng and Zhang, Guangming},
title = {Single-Cell RNA-Seq Revealed the Immune Microenvironment Reprogramming by Dexmedetomidine Treatment in Ischemic Stroke},
journal = {Molecular Neurobiology},
year = {2025},
doi = {10.1007/s12035-025-05237-1}
}
EUVIMED